Clinical Research Site

Memphis, Tennessee 38119

8 studies enrolling now · 17 studies all time

What they study most

ADHD, Binge-Eating Disorder, Depression, Fibromyalgia, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Migraine, Psoriatic Arthritis, Schizophrenia, Treatment Resistant Depression

Studies at this site

• Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol — Recruiting now
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD — Recruiting now
• A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) — Completed
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder — Enrolling by invitation
• Psoriatic Arthritis Study of Izokibep — Stopped early
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia — Stopped early
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed